Identifying CMV Retinitis as a Reversible Cause of Vision Loss in Persons with HIV-associated Meningitis
确定 CMV 视网膜炎是 HIV 相关脑膜炎患者视力丧失的可逆原因
基本信息
- 批准号:10752843
- 负责人:
- 金额:$ 31.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAfricaAfrica South of the SaharaBlindnessCaringCellsCellular PhoneCentral Nervous System InfectionsCollaborationsCryopreservationCryptococcal MeningitisCryptococcusCytomegalovirusCytomegalovirus RetinitisDNADetectionDevelopmentDiagnosisDiagnosticDiseaseDisease MarkerEarly treatmentEquipmentEvaluationEyeEye diseasesFundus photographyGanciclovirGeneral HospitalsGrantGuidelinesHIVHIV/AIDSHealthHospitalizationHospitalsImageImage EnhancementImaging technologyIncidenceIndividualInfectionInternal MedicineLogistic RegressionsMeasuresMeningeal TuberculosisMeningitisMeningoencephalitisMicrobiologyMinnesotaMycobacterium tuberculosisNeurologicOphthalmologistOphthalmologyOpportunistic InfectionsOrganPatientsPersonsPharmaceutical PreparationsPhysiciansPlasmaPlayPopulationPopulations at RiskPrevalenceResearchResource-limited settingRetinaRetinitisRiskRisk FactorsRoleSecureSensitivity and SpecificitySeveritiesSiteSurvivorsSymptomsTechnical ExpertiseTechnologyTimeTrainingUgandaUniversitiesViral Load resultViremiaVirusVisionVisualVisual impairmentVitreous humoradjudicationclinical examinationcombatdesigndiagnostic accuracyexperiencefundus imaginghigh riskhigh risk populationimprovedinstitutional capacityinterestlow and middle-income countriesmortalitynovelopportunistic pathogenportabilitypreventretinal imagingroutine carestandard of careteleophthalmologyviral detection
项目摘要
Project Summary
Vision loss is common in persons diagnosed with advanced HIV disease (CD4<200 cells/L) presenting
with central nervous system (CNS) infections, such as cryptococcal or TB meningitis. The prevalence of
cytomegalovirus (CMV) retinitis as a reversible cause of vision loss and the relationship of end-organ eye
disease and CMV viremia is poorly characterized in Africa. Our long term objective is to develop improved
guidelines and institutional capacity for ophthalmologic care relevant to low and middle income countries with
high burdens of HIV/AIDS.
The specific objective of this R21 project is to determine the prevalence of CMV retinitis in Ugandans living
with AIDS who are hospitalized with symptoms of meningitis. The project is designed to determine if new
smartphone technology could expand the reach of high quality ophthalmologic evaluations in these settings.
We additionally want to assess if detectable virus in different compartments of the body could predict the
development or severity of CMV end-organ disease in the eye.
Specific Aim 1. Determine the prevalence of CMV retinitis in hospitalized persons with HIV-associated
meningitis using mobile non-mydriatic fundus imaging by general physicians and compare the
diagnostic accuracy to trained ophthalmologist examinations.
We hypothesize undetected CMV retinitis accounts for a proportion of the vision impairment seen in
persons with HIV-associated meningitis that is otherwise thought irreversible. Using tele-ophthalmology-
based non-mydriatic fundus imaging, general hospital physicians will be able to accurately screen and
detect CMV retinitis with non-inferior accuracy as compared to trained ophthalmologists in Ugandans with
HIV-associated meningitis.
Specific Aim 2. Determine how baseline plasma CMV DNA concentrations correlate with CMV retinitis
diagnosis made by either clinical exam or vitreous humor virus detection (in deceased patients only).
We hypothesize detectable CMV DNA in baseline plasma predicts the presence of CMV retinitis and
correlates with CMV DNA in vitreous humor, which is a marker of disease activity/severity.
Overall, this project will improve our understanding of the prevalence of CMV retinitis in our population and
promote future research to combat reversible causes of vision loss in persons with HIV-associated meningitis.
We also aim to deepen and expand the collaborative research capacity among ophthalmology, internal
medicine, and microbiology departments at research sites throughout Uganda.
项目摘要
视力丧失在被诊断为晚期艾滋病毒疾病的人中很常见(CD4200Cells/L)
患有中枢神经系统(CNS)感染,如隐球菌或结核脑膜炎。疾病的流行
作为可逆性视力丧失原因的巨细胞病毒视网膜炎与眼的终末器官的关系
疾病和CMV病毒血症在非洲的特点很差。我们的长期目标是发展更好的
与低收入和中等收入国家相关的眼科保健指南和机构能力
艾滋病毒/艾滋病的高负担。
R21项目的具体目标是确定生活在乌干达人中CMV视网膜炎的患病率
因脑膜炎症状而住院的艾滋病患者。该项目旨在确定新的
智能手机技术可以在这些环境中扩大高质量眼科评估的覆盖范围。
此外,我们还想评估在身体不同部位检测到的病毒是否可以预测
眼部巨细胞病毒终末器官疾病的发展或严重程度。
具体目标1.确定艾滋病毒相关性住院患者中巨细胞病毒视网膜炎的患病率
全科医生使用移动式非散瞳眼底显像检查脑膜炎,并比较
受过训练的眼科医生检查的诊断准确性。
我们假设未被检测到的巨细胞病毒视网膜炎占视力损害的一部分
患有艾滋病毒相关性脑膜炎的人,否则被认为是不可逆转的。使用远程眼科技术-
基于非散瞳眼底成像,综合医院的医生将能够准确地筛查和
与训练有素的乌干达眼科医生相比,检测CMV视网膜炎的准确性毫不逊色
与艾滋病毒相关的脑膜炎。
特定目标2.确定基线血浆CMV DNA浓度与CMV视网膜炎的相关性
通过临床检查或玻璃体体液病毒检测作出诊断(仅适用于已故患者)。
我们假设基线血浆中可检测到的巨细胞病毒DNA可以预测巨细胞病毒视网膜炎和
与玻璃体液中的CMV DNA相关,这是疾病活动/严重程度的标志。
总体而言,这项计划将提高我们对巨细胞病毒视网膜炎在我们人群中的流行率的了解,以及
促进未来的研究,以对抗艾滋病毒相关性脑膜炎患者视力丧失的可逆原因。
我们还致力于深化和扩大眼科、内科和内科之间的合作研究能力
乌干达各地研究地点的医学和微生物学部门。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simon Arunga其他文献
Simon Arunga的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Multi-component interventions to reducing unhealthy diets and physical inactivity among adolescents and youth in sub-Saharan Africa (Generation H)
采取多方干预措施减少撒哈拉以南非洲青少年的不健康饮食和缺乏身体活动(H 代)
- 批准号:
10106976 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
EU-Funded
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
- 批准号:
ES/Y00860X/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Fellowship
Decolonization, Appropriation and the Materials of Literature in Africa and its Diaspora
非洲及其侨民的非殖民化、挪用和文学材料
- 批准号:
EP/Y024516/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Research Grant
Exploring "Actionable Information" for Learning Improvement in Rural East Africa: A Positive Deviance Approach
探索东非农村地区学习改进的“可行信息”:积极偏差方法
- 批准号:
24K00390 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ePowerCart - Affordable Mobile Clean Energy for Remote Communities in Rural Sub-Saharan Africa and India
ePowerCart - 为撒哈拉以南非洲和印度农村偏远社区提供经济实惠的移动清洁能源
- 批准号:
10076185 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Collaborative R&D
Protecting Women from Economic shocks to fight HIV in Africa (POWER)
保护非洲妇女免受经济冲击,抗击艾滋病毒 (POWER)
- 批准号:
MR/Y003837/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Fellowship
Tackling antimicrobial resistance across dentistry in Sub-Saharan Africa.
解决撒哈拉以南非洲牙科领域的抗菌素耐药性问题。
- 批准号:
MR/Y019695/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Research Grant
Water stressed cities: individual choice, access to water and pathways to resilience in sub-Saharan Africa
缺水城市:撒哈拉以南非洲地区的个人选择、水资源获取和恢复力途径
- 批准号:
MR/X022943/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Fellowship
The Open fracture National Evaluation (ONE) Study - South Africa: Improving outcomes in the care of open fractures in low resource settings
开放性骨折国家评估 (ONE) 研究 - 南非:改善资源匮乏地区开放性骨折的护理效果
- 批准号:
MR/Y00955X/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Fellowship
Recognising & supporting informal mhealth in Africa through grassroots interventions (REIMAGINE)
认识
- 批准号:
MR/Y015614/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Research Grant














{{item.name}}会员




